OptiNose (OPTN) — Cash Flow-to-Debt Ratio
OptiNose (OPTN) has a Cash Flow-to-Debt Ratio of 0.01x as of March 2025, meaning its operating cash flow of $1.67 Million could theoretically repay 0% of its total liabilities ($176.22 Million) in one year. See OptiNose (OPTN) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
OptiNose Cash Flow-to-Debt Ratio (2015–2024)
Historical debt coverage capacity for OptiNose across 10 annual periods. Also explore how fast is OptiNose growing its equity to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for OptiNose (2015–2024)
Year-by-year debt coverage analysis for OptiNose. For market capitalisation and broader financial context, see OptiNose (OPTN) total market value.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.27x | $-44.89 Million | $169.15 Million | ▼ -151.2% |
| 2023 | -0.11x | $-20.53 Million | $194.34 Million | ▲ +68.6% |
| 2022 | -0.34x | $-67.65 Million | $200.85 Million | ▲ +17.8% |
| 2021 | -0.41x | $-76.94 Million | $187.84 Million | ▲ +13.5% |
| 2020 | -0.47x | $-86.21 Million | $182.03 Million | ▲ +42.1% |
| 2019 | -0.82x | $-90.81 Million | $111.07 Million | ▲ +12.4% |
| 2018 | -0.93x | $-91.82 Million | $98.38 Million | ▼ -126.8% |
| 2017 | -0.41x | $-35.65 Million | $86.64 Million | ▼ -186.0% |
| 2016 | 0.48x | $21.72 Million | $45.39 Million | ▲ +171.9% |
| 2015 | -0.67x | $-28.71 Million | $43.16 Million | — |